250 related articles for article (PubMed ID: 21872335)
21. Aripiprazole in the treatment of Alzheimer's disease.
De Deyn PP; Drenth AF; Kremer BP; Oude Voshaar RC; Van Dam D
Expert Opin Pharmacother; 2013 Mar; 14(4):459-74. PubMed ID: 23350964
[TBL] [Abstract][Full Text] [Related]
22. Quinagolide in the management of prolactinoma.
Schultz PN; Ginsberg L; McCutcheon IE; Samaan N; Leavens M; Gagel RF
Pituitary; 2000 Dec; 3(4):239-49. PubMed ID: 11788012
[TBL] [Abstract][Full Text] [Related]
23. Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic.
Keck PE; McElroy SL
Expert Opin Investig Drugs; 2003 Apr; 12(4):655-62. PubMed ID: 12665420
[TBL] [Abstract][Full Text] [Related]
24. Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify).
Bergman J
Exp Clin Psychopharmacol; 2008 Dec; 16(6):475-83. PubMed ID: 19086768
[TBL] [Abstract][Full Text] [Related]
25. Difficulties in the medical treatment of prolactinoma in a patient with schizophrenia--a case report with a review of the literature.
Konopelska S; Quinkler M; Strasburger CJ; Ventz M
J Clin Psychopharmacol; 2008 Feb; 28(1):120-2. PubMed ID: 18204364
[No Abstract] [Full Text] [Related]
26. Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas.
Ferone D; Lastoria S; Colao A; Varrella P; Cerbone G; Acampa W; Merola B; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 1998 Jan; 83(1):248-52. PubMed ID: 9435450
[TBL] [Abstract][Full Text] [Related]
27. [Aripiprazole: a new atypical antipsychotic drug].
Fischer B; Davids E; Gastpar M
Fortschr Neurol Psychiatr; 2004 Sep; 72(9):497-502. PubMed ID: 15365912
[TBL] [Abstract][Full Text] [Related]
28. Management of psychosis associated with a prolactinoma: case report and review of the literature.
Ali S; Miller KK; Freudenreich O
Psychosomatics; 2010; 51(5):370-6. PubMed ID: 20833935
[TBL] [Abstract][Full Text] [Related]
29. Dopamine partial agonists: a new class of antipsychotic.
Lieberman JA
CNS Drugs; 2004; 18(4):251-67. PubMed ID: 15015905
[TBL] [Abstract][Full Text] [Related]
30. Receptor reserve-dependent properties of antipsychotics at human dopamine D2 receptors.
Tadori Y; Forbes RA; McQuade RD; Kikuchi T
Eur J Pharmacol; 2009 Apr; 607(1-3):35-40. PubMed ID: 19217900
[TBL] [Abstract][Full Text] [Related]
31. Effects of quinagolide (CV 205-502), a selective D2-agonist, on vascular reactivity in patients with a prolactin-secreting adenoma.
Bodmer CW; Atkin SL; Savage MW; Masson EA; White MC
Clin Endocrinol (Oxf); 1995 Jul; 43(1):49-53. PubMed ID: 7641411
[TBL] [Abstract][Full Text] [Related]
32. Successful treatment of a prolactinoma with the antipsychotic drug aripiprazole.
Bakker IC; Schubart CD; Zelissen PM
Endocrinol Diabetes Metab Case Rep; 2016; 2016():160028. PubMed ID: 27284453
[TBL] [Abstract][Full Text] [Related]
33. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
[TBL] [Abstract][Full Text] [Related]
34. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
Glaser B; Nesher Y; Barziliai S
J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
[TBL] [Abstract][Full Text] [Related]
35. Proptosis as the presenting sign of giant prolactinoma in a prepubertal boy: successful resolution of hydrocephalus by use of medical therapy.
Cackett P; Eunson G; Bath L; Mulvihill A
Future Oncol; 2012 Dec; 8(12):1621-6. PubMed ID: 23231524
[TBL] [Abstract][Full Text] [Related]
36. Aripiprazole and haloperidol: beneficial combination antipsychotic therapy for a schizophrenic patient.
Kuo J; Hwu HG
Clin Neuropharmacol; 2008; 31(3):173-5. PubMed ID: 18520984
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of macroprolactinomas with quinagolide (Norprolac)].
Tabarin A; Catargi B
Ann Endocrinol (Paris); 1997; 58(2):87-94. PubMed ID: 9239226
[TBL] [Abstract][Full Text] [Related]
38. Anejaculation as the presenting feature of pituitary microadenoma.
Nair S; Milsom S
Fertil Steril; 2008 Nov; 90(5):2012.e21-3. PubMed ID: 18394608
[TBL] [Abstract][Full Text] [Related]
39. Pituitary microadenoma treated with antipsychotic drug aripiprazole.
Wix-Ramos RJ; Paez R; Capote E; Ezequiel U
Recent Pat Endocr Metab Immune Drug Discov; 2011 Jan; 5(1):58-60. PubMed ID: 22074578
[TBL] [Abstract][Full Text] [Related]
40. Prolactin decrease and shift to a normal-like isoform profile during treatment with quinagolide in a patient affected by an invasive prolactinoma.
Guido R; Valenti S; Foppiani L; De Martini D; Cossu M; Giusti M
J Endocrinol Invest; 1997 May; 20(5):289-93. PubMed ID: 9258810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
